Virginia Commonwealth University

Running trials

• Not yet recruiting

  Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

  NCT05936931· Source

• Not yet recruiting

  Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury

  NCT07772323· Source

• Not yet recruiting

  Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry

  NCT05974644· Source

• Recruiting

  Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

  NCT07710534· Phase 2· Source

• Not yet recruiting

  Rethinking Early Airway Clearence Therapies

  NCT07696338· Source

• Not yet recruiting

  Colon Health Champion Program

  NCT07796334· Source

• Not yet recruiting

  Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)

  NCT07013396· Source

• Not yet recruiting

  Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy

  NCT07639086· Phase 2· Source

• Recruiting

  Autonomic and Renal Contributions to Hypertension With ADT

  NCT07848828· Phase 4· Source

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Source

• Recruiting

  A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

  NCT07143968· Phase 2· Source

• Recruiting

  Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  NCT07224360· Phase 2· Source

• Recruiting

  Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  NCT07227298· Phase 1/2· Source

• Recruiting

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· Phase 2/3· Source

• Recruiting

  Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

  NCT07284290· Phase 4· Source

• Recruiting

  Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

  NCT06794229· Phase 2· Source

• Enrolling by invitation

  Novel On-body Evaluation of Cardiac Health for Oncology

  NCT07158450· Source

• Recruiting

  A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  NCT06989437· Phase 2/3· Source

• Recruiting

  Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

  NCT06745908· Phase 3· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· Phase 3· Source

• Recruiting

  Enhancing Oral Cancer Awareness

  NCT06682494· Source

• Recruiting

  Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  NCT06964464· Phase 4· Source

• Recruiting

  Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  NCT06911632· Source

• Active, not recruiting

  P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

  NCT06468033· Phase 3· Source

• Recruiting

  The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

  NCT06854458· Source

• Recruiting

  FearLess in NeuroOncology

  NCT06989086· Source

• Recruiting

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  NCT06846281· Phase 3· Source

• Recruiting

  A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  NCT06944522· Phase 3· Source

• Recruiting

  Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

  NCT06846463· Phase 2· Source

• Recruiting

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· Phase 3· Source

• Recruiting

  Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  NCT06374238· Source

• Recruiting

  Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

  NCT06728072· Phase 2· Source

• Recruiting

  GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

  NCT06636123· Phase 1· Source

• Recruiting

  Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

  NCT06731413· Phase 2· Source

• Recruiting

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· Source

• Recruiting

  SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

  NCT06743126· Phase 3· Source

• Recruiting

  A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  NCT06562543· Phase 4· Source

• Recruiting

  EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

  NCT06212791· Source

• Recruiting

  Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

  NCT06660355· Phase 2· Source

• Recruiting

  Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  NCT06526195· Source

• Recruiting

  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  NCT06597019· Phase 3· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

  NCT06706674· Phase 3· Source

• Recruiting

  Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  NCT06654752· Source

• Recruiting

  A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  NCT06619561· Phase 2· Source

• Recruiting

  Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

  NCT06370000· Phase 4· Source

• Recruiting

  Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  NCT06541262· Phase 1/2· Source

• Active, not recruiting

  IC14 for Treatment of Acute Decompensated Heart Failure

  NCT06556810· Phase 1/2· Source

• Recruiting

  A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  NCT06504589· Source

• Recruiting

  Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

  NCT06248606· Phase 2· Source

• Recruiting

  ASSESS ALL ALS Study

  NCT06578195· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure10 recruiting
• Lung cancer8 recruiting
• Childhood cancers7 recruiting
• Acute myeloid leukemia4 recruiting
• Colorectal cancer4 recruiting
• Cystic fibrosis4 recruiting
• Fatty liver disease (MASLD/MASH)4 recruiting
• High blood pressure4 recruiting
• Prostate cancer4 recruiting
• Amyloidosis3 recruiting
• Multiple myeloma3 recruiting
• Parkinson disease3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Sickle cell disease3 recruiting
• Stroke3 recruiting
• ALS (motor neurone disease)2 recruiting
• Atrial fibrillation2 recruiting
• Autism2 recruiting
• Bipolar disorder2 recruiting
• Endometrial cancer2 recruiting
• Head and neck cancer2 recruiting
• Hepatitis B2 recruiting
• Melanoma2 recruiting
• Neuroblastoma2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Glioblastoma1 recruiting
• HIV1 recruiting
• Hodgkin lymphoma1 recruiting
• Kidney cancer1 recruiting
• Lewy body dementia1 recruiting
• Liver and biliary tract cancer1 recruiting
• Multiple sclerosis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Pompe disease1 recruiting
• Sarcoma1 recruiting
• Schizophrenia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  mHealth Intervention for Pain Self Management

  NCT07332377· Source

• Completed

  Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

  NCT06493253· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· Phase 2· Source

• Completed

  Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

  NCT06947395· Source

• Completed

  Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot Study

  NCT06567925· Source

• Completed

  A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

  NCT06676072· Source

• Completed

  Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

  NCT06688825· Source

• Completed

  Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer

  NCT06947382· Source

• Completed

  CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

  NCT06439420· Phase 2· Source

• Completed

  A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

  NCT06159725· Phase 1/2· Source

• Completed

  Improving Access to Community-Based Occupations Via a Rideshare Training Program

  NCT06323850· Source

• Completed

  Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca

  NCT06250751· Source

• Completed

  The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)

  NCT06062966· Phase 1· Source

• Completed

  Feasibility Study: Educational Genetic Test Video

  NCT06166758· Source

• Recruiting

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· Phase 3· Source

• Completed

  WE Project: 2.0 Grassroots Wellness Coaching (Phase 2)

  NCT06172582· Source

• Completed

  CALM: Managing Distress in Malignant Brain Cancer

  NCT06180460· Source

• Completed

  The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease

  NCT05924919· Source

• Completed

  Engaging Black Men in Colorectal Cancer Screening

  NCT05980182· Source

• Completed

  Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management

  NCT05544708· Source

• Terminated

  Antiretroviral Improvement Among Medicaid Enrollees

  NCT05477485· Source

• Recruiting

  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  NCT05727904· Phase 3· Source

• Completed

  Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke

  NCT05728866· Source

• Terminated

  A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

  NCT05317078· Phase 1· Source

• Terminated

  Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)

  NCT05605548· Early phase 1· Source

• Completed

  Effect of Parenting With Positive Interven on Comm Inclusion for Military Connected and Dependents With Autism

  NCT05580432· Source

• Withdrawn

  Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

  NCT05130346· Source

• Completed

  ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

  NCT05081245· Phase 2· Source

• Completed

  Vitamin E Dosing Study

  NCT04801849· Phase 2· Source

• Completed

  Istradefylline for Parkinson Disease With Cognitive Impairment

  NCT05333549· Phase 2· Source

• Completed

  Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

  NCT05225415· Phase 2· Source

• Completed

  Defining Endpoints in Becker Muscular Dystrophy

  NCT05257473· Source

• Terminated

  Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer

  NCT05263492· Phase 2· Source

• Completed

  A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

  NCT05198804· Phase 1/2· Source

• Completed

  Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir

  NCT05169580· Phase 1· Source

• Completed

  Afrezza® INHALE-1 Study in Pediatrics

  NCT04974528· Phase 3· Source

• Completed

  The PROMISE Pediatric Study 6 to 11 Years Old

  NCT04613128· Source

• Completed

  SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting

  NCT04746846· Source

• Completed

  CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

  NCT05130606· Source

• Completed

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· Phase 2· Source

• Completed

  Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

  NCT04697628· Phase 3· Source

• Completed

  Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

  NCT04463771· Phase 2· Source

• Completed

  Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

  NCT04609566· Phase 2· Source

• Completed

  LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma

  NCT04577807· Phase 2· Source

• Completed

  Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

  NCT04454463· Source

• Completed

  Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

  NCT04266197· Phase 2· Source

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Source

• Completed

  Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

  NCT04084080· Phase 3· Source

• Completed

  Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis

  NCT04166396· Early phase 1· Source

• Completed

  Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

  NCT06703346· Phase 2· Source